Inhibition of nucleic acid synthesis in P-388 lymphocytic leukemia tumor cells by helenalin and bis(helenalinyl)malonate in vivo. [electronic resource]
- Journal of pharmaceutical sciences Feb 1988
- 178-84 p. digital
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
0022-3549
10.1002/jps.2600770217 doi
Animals Antineoplastic Agents, Phytogenic--therapeutic use DNA, Neoplasm--biosynthesis IMP Dehydrogenase--antagonists & inhibitors In Vitro Techniques Leukemia P388--drug therapy Leukemia, Experimental--drug therapy Male Mice Neoplasm Proteins--biosynthesis RNA, Neoplasm--biosynthesis Sesquiterpenes--therapeutic use Sesquiterpenes, Guaiane Terpenes--therapeutic use Thioredoxins--antagonists & inhibitors